Syncona Ltd. has merged two of its companies, U.K.-based Gyroscope Therapeutics Ltd., a biotech developing gene therapy for retinal diseases, and U.S.-based Orbit Biomedical Ltd., a medical device company that targets delivery of gene and cell therapies into the retina, to create a single retinal gene therapy company.